Canagliflozin and risk of amputation in patients with type 2 diabetes

Canagliflozin and risk of amputation in patients with type 2 diabetes

Blog Article

cerini coffee and gifts products Sodium glucose co-transporter type 2 inhibitors (SGLT2) are a new effective group of oral hypoglygemic drugs for the treatment of diabetes type 2.At the moment there is no unanimous opinion on their safety.The article presents the data on clinical studies CANVAS and CANVAS-R and reports of the international database VigiBase (2015 - 2017) on the risk of amputation in patients with type bengals lunch box 2 diabetes undergoing treatment with canagliflozin.